Model Organisms in Drug Discovery

REFERENCES 181
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D.,
Bennett, H. A., et al. (2000). Functional discovery via a compendium of expression
profiles. Cell 102, 109–126.
Hwang, J. M., Chang, D. J., Kim, U. S., Lee, Y. S., Park, Y. S., Kaang, B. K. and Cho,
N. J. (1999). Cloning and functional characterization of a Caenorhabditis elegans
muscarinic acetylcholine receptor. Recept. Channels 6, 415–424.
Jang, M. J., Jwa, M., Kim, J. H. and Song, K. (2002). Selective inhibition of MAPKK WisI
in the stress-activated MAPK cascade of Schizosaccharomyces pombe by novel berberine
derivatives. J. Biol. Chem. 277, 12 388–12 395.
Janssen, S., Cuvier, O., Muller, M. and Laemmli, U. K. (2000). Specific gain- and loss-offunction
phenotypes induced by satellite-specific DNA-binding drugs fed to Drosophila
melanogaster. Mol. Cell 6, 1013–1024.
Jorgensen, E. M. and Mango, S. E. (2002). The art and design of genetic screens:
Caenorhabditis elegans. Nat. Rev. Genet. 3, 356–369.
Karim, F. D. and Rubin, G. M. (1998). Ectopic expression of activated Ras1 induces
hyperplastic growth and increased cell death in Drosophila imaginal tissues. Development
125, 1–9.
Kauffmann, R. C., Qian, Y., Vogt, A., Sebti, S. M., Hamilton, A. D. and Carthew, R. W.
(1995). Activated Drosophila Ras1 is selectively suppressed by isoprenyl transferase
inhibitors. Proc. Natl. Acad. Sci. USA 92, 10 919–10 923.
Kazanietz, M. G., Lewin, N. E., Bruns, J. D. and Blumberg, P. M. (1995). Characterization
of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity
phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements,
and inhibitor sensitivity. J. Biol. Chem. 270, 10 777–10 783.
Kimble, J. and Simpson, P. (1997). The LIN-12/Notch signaling pathway and its
regulation. Annu. Rev. Cell Dev. Biol. 13, 333–361.
Koh, B. and Crews, C. M. (2002). Chemical genetics. A small molecule approach to
neurobiology. Neuron 36, 563–566.
Kwok, B. H., Koh, B., Ndubuisi, M. I., Elofsson, M. and Crews, C. M. (2001). The antiinflammatory
natural product parthenolide from the medicinal herb Feverfew directly
binds to and inhibits IkappaB kinase. Chem. Biol. 8, 759–766.
Lambie, E. J. and Kimble, J. (1991). Two homologous regulatory genes, lin-12 and glp-1,
have overlapping functions. Development 112, 231–240.
Levitan, D. and Greenwald, I. (1995). Facilitation of lin-12-mediated signalling by sel-12, a
Caenorhabditis elegans S182 Alzheimer’s disease gene. Nature 377, 351–354.
Levitan, D. and Greenwald, I. (1998). LIN-12 protein expression and localization during
vulval development in C. elegans. Development 125, 3101–3109.
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H.,
Yu, C. E., et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer’s
disease locus. Science 269, 973–977.
Lewis, J. A., Fleming, J. T., McLafferty, S., Murphy, H. and Wu, C. (1987). The levamisole
receptor, a cholinergic receptor of the nematode Caenorhabditis elegans. Mol. Pharmacol.
31, 185–193.
Li, X. and Greenwald, I. (1997). HOP-1, a Caenorhabditis elegans presenilin, appears to be
functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1
signaling. Proc. Natl. Acad. Sci. USA 94, 12 204–12 209.
Li, Y. M., Xu, M., Lai, M. T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T.,
et al. (2000). Photoactivated gamma-secretase inhibitors directed to the active site
covalently label presenilin 1. Nature 405, 689–694.